Member Info for comek2

Popeye62, you know nothing about investing let alone evaluating companies or how revenues reflect or impact their value or mcap. Still eating stale spinach maybe. You keep getting wrong on IMM as I reminded there too. Brush up your reading skills first before you attempt companies’ evaluationsc.

There you go another contradictory post Marty130 lol

Marty130, still in Jekyll and Hyde mode I see. You should see a psychologist, everyone one of your post contradict the previous one and the future too lol. Maybe you’ve got nothing to do with your time spending all day here. It’s been sunny outside for the last 3 days btw.

Popeye62, you are spiting rubbish here just as you do on IMM board. Double the revenues for 2027 and “they aren’t impressive” lol. Institutions look for medium to long term revenues and these suit them just fine unlike you trading and chasing rainbows and losing in the process. Not enough spinach for your breakfast.

Excellent revenues update, more than twice the previous prediction for 2027. I see idiots complaining about 2 years wait lol. First sp is forward looking and more importantly if as PI you’re not interested IIs look for such position medium to long term performance. Expect to see plenty of institutions piling in which not increase the price drastically but also stabilise it against casino type PIs investors lol.

Excellent endorsement from such calibre as Prof. Perrie having worked with the biggest big pharma and internal bodies such as the Who. Did she say she aim to accelerate Nuvec to commercialisation? I see the start of a rerate similar to IMM and HEMO which multi bagged 10x and 6x respectively in the last 6 weeks.

Placing oversubscribed by over 25% and completed on the same day, shows institutions’ great interest. 4 directors subscribed, including some that had more than enough showing great confidence from ‘insiders’. Follow the money!!! Those who sold today or didn’t top will regret by the end of the week starting tomorrow. This Thursday we should have financial results which will be mouthwatering if only wrt to the forward looking statement now that we have partnership with Tempus. I believe in foresight not hindsight, and glad I topped up twice as I posted this morning.

Don’t listen to the derampers they’re looking to cheat you out of your shares to buy cheaply. This an excellent raise to fund the commercialisation of the unique test as it is CLEARLY STATED IN THE RNS. They spent £100m bet the test development and FDA approval, whats 4m in comparison? Just reread the message again of Tempus’ CEO and today’s rns and relax.

Louise, are you 82 years old? It would appear to be the case from your posts lol. Raising £4.5 million to start commercialisation of a unique test for 15 million patients US market, 7 million U.K. patients, and 250 millions worldwide with a unique distribution and biggest distribution platform from a $15 billion worth US Tempus is a master stroke. The sp small fall is either the mms trying to scare people into selling to accumulate cause thru understand the announcements, or inexperience investors selling. But this anomaly will correct itself soon. American investors understand better the stock market, let’s see when the U.S. opens this afternoon. I have the felling they’ll take the sp to end very blue here.

I’ve topped up twice, 47607 at 10.49 and 46456 at 10.75, paying £5k each. This is a no brainer.

This will be up soon and finish very blue indeed. Just mms manipulating to accumulate some shares as they know the demand is very strong. Look at my earlier post I predicted exactly their tactics at the open: bring down the sp to scare investors into selling them take it back which they did within few minutes. Watch this space it the sp fill finish very blue today and turn blue well before 10 am.

Lol mms bringing sp down just as I warned, watch they take it up into the blues before 8:30 lol

A warning to those not familIsrael with mms tactics, they may play their tricks of lowering the sp to get shares only to take up few moments later.

I forgot to add we PIs are offered a juicy discount come Thursday the sp should well over 15p if not 20p imo.

Excellent raise a 39% premium based on a 3 months average. In these tough market over the last 2/3 years companies have been offering over 50% discount eg Polx 73% yet with a unique pharma tech product. Directors showing confidence participating in the placing. There are a lot Aim cos that raise for directors’ lifestyle living. This raise is needed to turbocharge commercialisation of the test with Tempus and as such will set the sp ablaze, is the norme is such cases. Remember companies list on the stock market to raise fund to grow and expend. RENX is one of the successful ones. Therefore I expect the share price to respond very well today and beyond.

Validpoint, and the excellent progress IMM has made since won’t it erase and more the dilution you speak off? The diagnostic test alone is worth more than £1.60. Change your handle if you don’t want to be accused of spouting “arrogant idiotie”.

Tempus CEO sees $1 trillion cash-flow for Tempus. Can you imagine what would be the value to RENX’ part of the pie?

https://x.com/jkeynesalpha/status/1939456814581436512?s=46

BusinessOwner, I ask you in my turn if you could provide the link please, thanks. Same goes for Rocket79 lol. Pleople should really links when they quote. Cheers all here is to an excellent next week and beyond. We have a lot to catch up with IMM and HEMO having bagged 10x and 6x respectively in the last month. Maybe the financial update expected this Thursday will do it.

LadyBayDarling, the test is $950 each, not £10 lol. And it will be selling like confetti being a unique test with the distribution platform of Tempus, a $15 billion mcap US co.

LadyBayDarling

Posts: 249

Price: 10.25

No Opinion

RE: .Today 08:44

Funding, We've just signed a collaboration with a trillion dollar company for millions of tests at £10 each,

MIKODX, no placing as per the CEO statement. The time it took to write your pop, RENX sold 12z of their unique test price at $950 each, without the backing of Tempus top notch distribution platform, a $15 billions mcap US company. The test will generate $ like confetti.